Excess Bed Days and Hospitalization Costs Associated With 30‐Day Complications Following Catheter Ablation of Atrial Fibrillation
Journal of the American Heart Association · 2023
DOI: 10.1161/jaha.123.030236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2023. Verfasst von Linh Ngo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Greater Brisbane Clinical School, Faculty of Medicine The University of Queensland Brisbane Queensland Australia. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pericardial Effusion, Catheter Ablation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The incidence and type of complications following catheter ablation of atrial fibrillation have been extensively examined, but the impact associated with these complications on the length of stay and hospitalization costs is unknown. Methods and Results This cohort study included 20 117 adult patients (mean age 62.6±11.4 years, 30.3% women, median length of stay 1 day [interquartile range 1–2 days]) undergoing atrial fibrillation ablation in financial years 2011 to 2017 in Australia with available cost data from the National Hospital Cost Data Collection, which determines government reimbursement of health services provided. The primary outcome was the costs associated with complications occurring up to 30 days postdischarge adjusted for inflation to 2021 Australian dollars. We used generalized linear models to estimate the increase in length of stay and cost associated with complications, adjusting for patient characteristics. Within 30 days of hospital discharge, 1151 (5.72%) patients experienced a complication with bleeding (3.35%) and pericardial effusion (0.75%) being the most common. On average, the occurrence of a complication was associated with an adjusted 3.3 (95% CI, 3.1–3.6) excess bed days of hospital care (totaling 3851 days), and a $7812 (95% CI, $6754–$8870) increase in hospitalization cost (totaling $9.0 million). Most of the total excess cost was attributable to bleeding ($3.8 million, 41.9% of total excess cost) and pericardial effusion ($1.6 million, 18.2%).
Conclusions
Complications following atrial fibrillation ablation were associated with significant increase in length of stay and hospitalization costs, most of which were attributable to bleeding and pericardial effusion. Strategies to improve procedural safety and reduce health care costs should focus on these complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Greater Brisbane Clinical School, Faculty of Medicine The University of Queensland Brisbane Queensland Australia.
- Department of Cardiology, The Prince Charles Hospital Brisbane Queensland Australia.
- QIMR Berghofer Medical Research Institute Brisbane Queensland Australia.
- College of Medicine and Public Health Flinders University Adelaide South Australia Australia.
- Department of Cardiovascular Medicine Flinders Medical Centre Adelaide South Australia Australia.
ORCID-Profile: Linh Ngo, Russell Denman, Karen Hay, Billingsley Kaambwa, Anand Ganesan
Zitieren
APA
Ngo, L., Denman, R., Hay, K., Kaambwa, B., Ganesan, A., & Ranasinghe, I. (2023). Excess Bed Days and Hospitalization Costs Associated With 30‐Day Complications Following Catheter Ablation of Atrial Fibrillation. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.030236
Vancouver
Ngo L, Denman R, Hay K, Kaambwa B, Ganesan A, Ranasinghe I. Excess Bed Days and Hospitalization Costs Associated With 30‐Day Complications Following Catheter Ablation of Atrial Fibrillation. Journal of the American Heart Association. 2023. doi:10.1161/jaha.123.030236
BibTeX
@article{Ngo2023,
author = {Ngo, Linh and Denman, Russell and Hay, Karen and Kaambwa, Billingsley and Ganesan, Anand and Ranasinghe, Isuru},
title = {Excess Bed Days and Hospitalization Costs Associated With 30‐Day Complications Following Catheter Ablation of Atrial Fibrillation},
journal = {Journal of the American Heart Association},
year = {2023},
doi = {10.1161/jaha.123.030236}
}
EUVIMED